[1] Rosei EA, Muiesan ML, Salvetti M, et al. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy [J]. J Am Soc Nephrol, 2006, 17 (4 Suppl 2): S104-S108.
[2] Doering CW, Jalil JE, Janicki JS, et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy[J]. Cardiovasc Res, 1998, 22(5): 686-695.
[3] Simone GD, Kizer JR, Chinali M, et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the strong heart study [J]. AJH, 2005, 18 (2 Pt 1):191-196.
[4] Stansfield WE, Rojas M, Corn D, et al. Characterization of a model to independently study regression of ventricular hypertrophy [J]. J Surg Res, 2007, 142(2): 387-393.
[5] Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertension heart disease [J]. Progr Cardiovasc Dis, 2006, 8(5): 326-341.
[6] Li J, Doerffel Y, Hocher B, et al. Inflammation in the genesis of hypertension and its complications-the role of angiotensin Ⅱ [J]. Nephrol Dial Transplant, 2007, 22(11): 3107-3109.
[7] 李昌繁, 江时森. 心力衰竭动物模型的研究进展[J].医学研究生学报, 2007, 20(5):532-534.
[8] Brooks WW, Conrad CH, Robinson KG, et al. L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat[J]. Am J Hypertens, 2009, 22(2): 228-234.
[1]刘蓉,张丹,杨玲.2型糖尿病患者尿微量白蛋白与左室肥厚的关系[J].医学研究与战创伤救治(原医学研究生学报),2015,17(05):506.[doi:10.3969/j.issn.1672-271X.2015.05.018]
LIU Rong,ZHANG Dan,YANG Ling..The relationship between microalbuminuria and left ventricular hypertrophy in type 2 diabetes[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(01):506.[doi:10.3969/j.issn.1672-271X.2015.05.018]